Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2002 Mar 1;93(2):92–97. [Article in French] doi: 10.1007/BF03404545

Facteurs associés à la non-observance du traitement de la tuberculose active, Montréal 1992–1995

Magalie Cator 13,23,✉, Paul Brassard 23,33, Slobodan Ducic 23, Kate Culman 43
PMCID: PMC6979829  PMID: 11963527

Abstract

Objective: To determine the extent of non-compliance with antituberculosis treatment in Montreal and whether it is influenced by the characteristics of the health care setting.

Methods: Retrospective medical and public health chart review of tuberculosis patients reported to the Montreal-Centre Department of Public Health between 1992–1995. A non-compliant patient is defined as one who has taken less than 80% of prescribed antituberculosis medication.

Results: Among patients for whom the compliance status was available, 19.8% were noncompliant. In univariate analysis, risk factors significantly associated with non-compliance included: living alone, birth in an endemic country for tuberculosis, side effects related to the medication, and follow-up in a clinic not specialized for tuberculosis. In multivariate analysis, increase of age by one unit (OR: 1.1; 95% CI: 1.02-1.1), and risk factors such as alcoholism (OR: 33.8; 95% CI: 5.8-194.4) and being HIV positive (OR: 8.9; 95% CI: 2.9-26.6) were independently associated with non-compliance.

Conclusion: Non-observance seemed to be associated with patients’ characteristics rather than health care system characteristics.

Footnotes

Cet article a été réalisé dans le cadre de sa Maîtrise en Santé Communautaire à l’Université de Montréal. RÉFÉRENCES

Références

  • 1.Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis. 1993;74:32–37. doi: 10.1016/0962-8479(93)90066-7. [DOI] [PubMed] [Google Scholar]
  • 2.Pablos-Mendez A, Knirsch CA, Barr G, Lerner BH, Frieden TR N. -adherence in tuberculosis treatment. Predictors and consequences in New York City. Am J Med. 1997;102:164–70. doi: 10.1016/S0002-9343(96)00402-0. [DOI] [PubMed] [Google Scholar]
  • 3.Standards Committee (Tuberculosis) of the Canadian Thoracic Society. Canadian Tuberculosis Standards, 4th edition. Canadian Lung Association, 1996.
  • 4.Enarson DA, Grosset A, Mwinga A, Hershfield ES, O’Brien R, Cole S, et al. The challenge of tuberculosis: Statements on global control and prevention. Lancet. 1995;346:809–19. doi: 10.1016/S0140-6736(95)91623-7. [DOI] [PubMed] [Google Scholar]
  • 5.Earnest M, Sbarbaro JA. Tuberculosis: Adherence to regimens and directly observed therapy. In: Rom WN, Garay SM, editors. Tuberculosis. New York: Little, Brown and Company Inc.; 1996. [Google Scholar]
  • 6.Cuneo WD, Snider D Jr. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med. 1989;10(3):375–80. [PubMed] [Google Scholar]
  • 7.Addington W. Patient compliance: The most serious remaining problem in the control of tuberculosis in the United States. Chest. 1979;76(6Suppl):741–43. doi: 10.1378/chest.76.6_Supplement.741. [DOI] [PubMed] [Google Scholar]
  • 8.Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147:1311–20. doi: 10.1164/ajrccm/147.5.1311. [DOI] [PubMed] [Google Scholar]
  • 9.Swanson D, Starke J D-r t i pediatrics. Pediatr Clin North Am. 1995;42(3):553–81. doi: 10.1016/S0031-3955(16)38979-9. [DOI] [PubMed] [Google Scholar]
  • 10.Werhane MJ, Snuckst-Torbeck G, Schraufnagel DE. The tuberculosis clinic. Chest. 1989;96(4):815–18. doi: 10.1378/chest.96.4.815. [DOI] [PubMed] [Google Scholar]
  • 11.Long R, editor. Canadian Tuberculosis Standards. 5th edition. Ottawa: Canadian Lung Association; 2000. [Google Scholar]
  • 12.Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993;5(2):149–77. [PubMed] [Google Scholar]
  • 13.World Health Organization. Tuberculosis. Wkly Epidemiol Rec. 1995;70(11):73–77. [PubMed] [Google Scholar]
  • 14.Culman K, Brassard P, Tannenbaum T. The epidemiology of tuberculosis in Montreal. Tuber Lung Dis. 1996;77(Suppl2):123. [Google Scholar]
  • 15.FitzGerald JM, Garcia-Cruz A, Elwood RK, Enarson DA. Cohort evaluation of treatment results, British Columbia (abstract) Tuber Lung Dis. 1995;76(Suppl2):80. doi: 10.1016/0962-8479(95)90311-9. [DOI] [Google Scholar]
  • 16.Wobeser W, Yuan L, Naus M. Outcome of pulmonary tuberculosis treatment in the tertiary care setting — Toronto 1992/93. Tuberculosis treatment completion study group. CMAJ. 1999;160(6):789–94. [PMC free article] [PubMed] [Google Scholar]
  • 17.Global Tuberculosis Programme. Global Tuberculosis Control. WHO Report 1997 [rep no WHO/TB/97.225] Geneva: World Health Organization; 1997. pp. 9–15. [Google Scholar]
  • 18.Schluger N, Ciotoli C, Cohen D, Johnson H, Rom WN. Comprehensive tuberculosis control for patients at high risk for non-compliance. Am J Respir Crit Care Med. 1995;151(5):1486–90. doi: 10.1164/ajrccm.151.5.7735604. [DOI] [PubMed] [Google Scholar]
  • 19.Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, Homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144(4):745–49. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  • 20.Connoly C, Davies GR, Wilkinson G. Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa. Int J Tuberc Lung Dis. 1999;3(12):1081–87. [PubMed] [Google Scholar]
  • 21.World Health Organization. Global Tuberculosis Programme. Tuberculosis and HIV Research: Working Towards Solutions. Results of a WHO Workshop on the formulation of a new TB/HIV research strategy. 1995. [Google Scholar]
  • 22.Geduld J, Brassard P, Culman K, Tannenbaum TN. Testing for HIV among patients with tuberculosis in Montreal. Clin Invest Med. 1999;22(3):111–18. [PubMed] [Google Scholar]
  • 23.Reichman LB. Compliance in developed nations. Tubercle. 1987;68(suppl.):25–29. doi: 10.1016/S0041-3879(87)80017-X. [DOI] [PubMed] [Google Scholar]
  • 24.Haynes RB, Taylor DW, Sackett D Eds, editors. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979. [Google Scholar]
  • 25.Anastasatu C, Mihailescu P, Didilescu C, Ibraim E, Lugoji D, Chiotan D. Tuberculosis in the elderly: Sociomedical aspects. Pneumoftiziologia. 1993;42(1–2):23–27. [PubMed] [Google Scholar]
  • 26.Teixeira JJ, Lefevre F, Castro LL, De Pinho Spinola AW. Drug compliance and the elderly: Who is publishing, Where and when? Cad Saude Publica. 2000;16(1):139–44. doi: 10.1590/S0102-311X2000000100014. [DOI] [PubMed] [Google Scholar]
  • 27.Cline CM, Bjorck-Linne AK, Israelsson B, Willenheimer RB, Erhardt LR. Non-compliance and knowledge of prescribed medication in elderly patients with heart failure. Eur J Heart Fail. 1999;1(2):145–49. doi: 10.1016/S1388-9842(99)00014-8. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES